Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies.

The members of the deliberative committee unanimously recognized the therapeutic value of tisagenlecleucel (Kymriah) in the treatment of children and young adults with relapsed

Neverthe- less, this correlation between RUNX1 and CBFA2T3 expression is retrieved under enforced expression or depletion of RUNX1 or CBFA2T3 in two BCP-ALL cell lines, the REH

In [37] the performance of consensus algorithms in terms of providing a fast convergence rate involving communication delays, was studied for second order multi agent systems..

Keywords: zinc oxide; iron oxide; nanoparticles; fucoidan; atherothrombosis; MRI; optical imaging; contrast agents.. Molecules 2019, 24, 962;

The projects were Human Resource Development for the Mekong Region (1993-2007) on vegetable research; Social Forestry Support Programme (1994-2002) for development of five

Encouraged by these promising results, we evaluated cell death induced by PKHB1 (the first- described serum- stable CD47- agonist peptide) on CEM and MOLT- 4 human

Detection of Minimal Residual Disease in B Cell Acute Lymphoblastic Leukemia Using an Eight-Color Tube with Dried Antibody Reagents...

Conclusions: Hypoxia is a factor in leukemia cell resistance and for two conventional chemotherapies modulates cell death signaling pathways without affecting total cell density or